Kentucky Attorney General Russell Coleman announced that $19.8 million was awarded to 75 Kentucky organizations to combat the ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...

Dr. Peter Marks, the FDA's top vaccine official, resigns amid pressure from Health Secretary Robert F. Kennedy Jr., ...

Nerve damage isn’t just about pain—it’s about decay. Arialief includes Alpha Lipoic Acid (ALA) because it does what few ...

Critical Path Institute® and Boston Medical Center published results for six biomarkers that could improve the early and accurate detection of kidney injury, leading to both the development of safer ...

Looking ahead, Leen Kawas believes that the successful integration of AI into drug discovery will require thoughtful ...